Waterland sells Mauritsklinieken to Holland Venture

Holland Venture, a Dutch growth and buyout capital firm mostly investing in healthcare and technology companies, invested alongside the management team.

As part of the deal, shares were acquired from founding group SJMG Health Investments, an independent investment firm focusing on the Dutch healthcare sector, and from Waterland which acquired a majority stake in the group in 2010.

The investment will help Mauritsklinieken further its collaboration with hospitals and general practitioners, and to increase its care offering by expanding geographically and exploring related specialisms. Those changes will be carried out both organically and through acquisitions, the company said in a statement.

In December last year, Holland Venture raised €55m for its latest fund, Holland Venture Entrepreneurs Fund III. The vehicle provides buyout and growth capital to Dutch SMEs in the healthcare and tech sectors. Pursuing a strategy similar to previous generations, the vehicle typically focuses on businesses with a turnover of up to €60m, investing equity tickets of €3-13m. The GP aims to complete around 10-12 transactions through the fund.

Company
Established in 2004, Mauritsklinieken is an operator of dermatology clinics. The group operates in the Netherlands and provides dermatologic and cosmetic care for various skin conditions.

In 2014, Mauritsklinieken performed more than 25,000 procedures and employed 22 specialists. Headquartered in The Hague, it has additional branches in Utrecht, Amsterdam and Nijmegen.

People
Holland Venture – Ewout Prins (managing partner).
Mauritsklinieken – Ivo Boslooper (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Buyouts
• Benelux
• Healthcare
• Benelux
• Netherlands
• Secondary buyout